This site is intended for healthcare professionals

Sign in
Go to /sign-in page

You can view 5 more pages before signing in

Insulin - human to analogue transfer

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

Insulin - human to analogue transfer guide

  • actrapid (R) - if conversion of actrapid to analogue then switch can be made to a very short acting analogue (e.g. insulin aspart or insulin lispro) with a 10% dose reduction as a precaution
  • mixtard 30 (R) - if conversion to an analogue then switch to an biphasic analogue insulin e.g. biphasic insulin aspart (NovoMix (R) 30) with a 10% dose reduction as a precaution
  • insulatard (R) - if conversion to an anlogue then swith to a long-acting analogue (e.g. insulin glargine or insulin detemir) with a 10% dose reduction as a precaution

Reference:

  1. Novo Nordisk (August 2005). Human to Analogue Transfer Guide.

Related pages

Create an account to add page annotations

Create a free account

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.